t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma

Leukemia

Volumn 17, Issue 10, 2003, Pages 2032-2035

  Garand, R ^a   Avet Loiseau, H ^a   Accard, F ^a   Moreau, P ^a   Harousseau, J L ^a   Bataille, R ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Cytogenetics; Morphology; Multiple myeloma

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BONE MARROW BIOPSY; CANCER CELL; CANCER INCIDENCE; CELL HETEROGENEITY; CELL MATURATION; CELL STRUCTURE; CHROMATIN STRUCTURE; CHROMOSOME 13; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 4; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; TUMOR VOLUME; CHROMOSOME 11; CHROMOSOME 14; CHROMOSOME MAP; CLASSIFICATION; GENE TRANSLOCATION; GENETICS; PATHOLOGY;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MULTIPLE MYELOMA; PLASMA CELLS; TRANSLOCATION, GENETIC;

EID: 0142151221     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403091     Document Type: Article

References (11)

1. Greipp PR, Raymond NM, Kyle RA, O'Fallon WM. Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood 1985; 65: 305-310.
2. Carter A, Hocherman I, Linn S, Cohen Y, Tatarsky I. Prognostic significance of plasma cell morphology in multiple myeloma. Cancer 1987; 60: 1060-1065.
3. Goasguen JE, Zandecki M, Mathiot C, Scheiff JM, Bizet M, Ly-Sunnaram B et al. Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology. Leukemia Res 1999; 23: 1133-1140.
4. Greipp PR, Leong T, Bennett JM, Gaillard JP, Klein B, Stewart JA et al. Plasmablastic morphology - an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by ECOG myeloma laboratory group. Blood 1998; 91: 2501-2507.
5. Moreau P, Facon T, Leleu X, Morineau N, Huyghe P, Harousseau JL et al. Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy. Blood 2002; 100: 1579-1583.
6. Fonseca R, Blood EA, Oken MM, Kyle RA, Dewald GW, Bailey RJ et al . Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 2003; 101: 4569-4575.
7. Avet-Loiseau H, Facon T, Grosbois B, Magrangeas F, Rapp MJ, Harousseau JL et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features and clinical presentation. Blood 2002; 99: 2185-2191.
8. Hoyer JD, Hanson CA, Fonseca R, Greipp PR, Dewald GW, Kurtin PJ. The t(11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study. Am J Clin Pathol 2000; 113: 831-837.
9. Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA et al. Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients. Blood 2002; 99: 3735-3741.
10. Robillard N, Avet-Loiseau H, Garand R, Moreau P, Pineau D, Rapp MJ et al. CD20 is associated with a small mature plasma-cell morphology and t(11;14) in multiple myeloma. Blood. Prepublished April 17, 2003; doi:10.1182/blood-2002-11-3333.
11. Avet-Loiseau H, Garand R, Lodé L, Harousseau JL, Bataille R. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE and nonsecretory multiple myeloma variants. Blood 2003; 101: 1570-1571.